My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Allakos Inc. - Common Stock (NQ:ALLK)

0.3291 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Allakos Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 14, 2024

Via Benzinga

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 17, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 17, 2024

Via Benzinga

Gold Down 1%; PNC Financial Posts Upbeat Earnings ↗

January 16, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday. The Dow traded down 0.93% to 37,243.85 while the NASDAQ fell 0.58% to 14,885.45. The...

Via Benzinga

Topics Stocks

Where Allakos Stands With Analysts ↗

December 18, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Allakos ↗

November 28, 2023

Via Benzinga

Why Shares of Allakos Are Up Wednesday ↗

September 27, 2023

The stock is bouncing back from a recent 52-week low.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 16, 2024

Via Benzinga

Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue ↗

January 16, 2024

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.46% to 37,421.80 while the NASDAQ fell 0.02% to...

Via Benzinga

Topics Stocks

Why Is Allakos (ALLK) Stock Down 57% Today? ↗

January 16, 2024

Allakos stock is falling hard on Tuesday as investors in ALLK react to two of the company's Phase 2 clinical trials failing.

Via InvestorPlace

Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50% ↗

January 16, 2024

Allakos reports disappointing topline data from phase 2 trials for lirentelimab in atopic dermatitis and chronic spontaneous urticaria. Company undergoes restructuring to focus on AK006, extending cash...

Via Benzinga

Dow Dips 200 Points; Goldman Sachs Earnings Top Views ↗

January 16, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ...

Via Benzinga

Topics Stocks

Analyst Ratings for Allakos ↗

May 12, 2023

Via Benzinga

Allakos: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Why Allakos Stock Was Heating Up Today ↗

March 07, 2023

A notable analyst upgrade had investors piling into this clinical-stage biotech stock today.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 16, 2024

Via Benzinga

Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive ↗

December 18, 2023

Shares of Allakos Inc (NASDAQ: ALLK) were climbing in early trading on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 09, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning!

Via InvestorPlace

Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside ↗

September 27, 2023

JMP Securities initiated coverage on Allakos Inc (NASDAQ: ALLK), noting novel monoclonal antibodies targeting Siglec (sialic acid immunoglobulin-like lectin) receptors on immune cells that are drivers...

Via Benzinga

Where Allakos Stands With Analysts ↗

March 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗

September 27, 2023

Via Benzinga

Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket ↗

September 12, 2023

Gainers AgileThought, Inc. (NASDAQ: AGIL) shares rose 72.5% to $0.2160 in pre-market trading after declining 12% on Monday.

Via Benzinga

Top 5 Health Care Stocks That Could Blast Off This Month ↗

August 21, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 07, 2023

Via Benzinga

Why Allakos Stock Skyrocketed Nearly 9% Higher Today ↗

May 12, 2023

The company is poised to report a critical set of clinical data in the coming months.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023 ↗

May 12, 2023

Via Benzinga

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 07, 2023

Via Benzinga

Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday ↗

March 07, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 07, 2023

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.